[go: up one dir, main page]

AR094935A1 - Tosilato de n-hidroxi-4-{2-[3-(n,n-dimetilaminometil)benzofuran-2-ilcarbonil-amino]etoxi}benzamida (abexinostat) - Google Patents

Tosilato de n-hidroxi-4-{2-[3-(n,n-dimetilaminometil)benzofuran-2-ilcarbonil-amino]etoxi}benzamida (abexinostat)

Info

Publication number
AR094935A1
AR094935A1 ARP140100648A ARP140100648A AR094935A1 AR 094935 A1 AR094935 A1 AR 094935A1 AR P140100648 A ARP140100648 A AR P140100648A AR P140100648 A ARP140100648 A AR P140100648A AR 094935 A1 AR094935 A1 AR 094935A1
Authority
AR
Argentina
Prior art keywords
benzofuran
amino
abexinostat
ilcarbonil
dimethylaminome
Prior art date
Application number
ARP140100648A
Other languages
English (en)
Inventor
Pimont-Garro Anne
Letellier Philippe
Original Assignee
Servier Lab
Pharmacyclics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48521256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR094935(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab, Pharmacyclics Inc filed Critical Servier Lab
Publication of AR094935A1 publication Critical patent/AR094935A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)

Abstract

Reivindicación 1: Tosilato de N-hidroxi-4-{2-[3-(N,N-dimetilaminometil)benzofuran-2-ilcarbonil-amino]etoxi}benzamida, o uno de sus solvatos. Reivindicación 2: Sal de tosilato de abexinostat de fórmula (1). Reivindicación 3: Sal según la reivindicación 1 ó 2 de fórmula (2).
ARP140100648A 2013-03-04 2014-02-28 Tosilato de n-hidroxi-4-{2-[3-(n,n-dimetilaminometil)benzofuran-2-ilcarbonil-amino]etoxi}benzamida (abexinostat) AR094935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1351898A FR3002733B1 (fr) 2013-03-04 2013-03-04 Nouveau sel de l'abexinostat, forme cristalline associee,leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
AR094935A1 true AR094935A1 (es) 2015-09-09

Family

ID=48521256

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100648A AR094935A1 (es) 2013-03-04 2014-02-28 Tosilato de n-hidroxi-4-{2-[3-(n,n-dimetilaminometil)benzofuran-2-ilcarbonil-amino]etoxi}benzamida (abexinostat)

Country Status (39)

Country Link
US (3) US9115108B2 (es)
EP (2) EP2964622B1 (es)
JP (2) JP6449177B2 (es)
CN (2) CN109734690B (es)
AR (1) AR094935A1 (es)
AU (2) AU2014224456B2 (es)
BR (1) BR112015021443A2 (es)
CA (1) CA2903369C (es)
CL (1) CL2015002488A1 (es)
CR (1) CR20150456A (es)
CY (1) CY1119147T1 (es)
DK (1) DK2964622T3 (es)
DO (1) DOP2015000215A (es)
EA (2) EA030689B1 (es)
ES (1) ES2632471T3 (es)
FR (1) FR3002733B1 (es)
GE (1) GEP201706760B (es)
HR (1) HRP20171041T1 (es)
HU (1) HUE035299T2 (es)
IL (1) IL241038B (es)
JO (1) JO3402B1 (es)
LT (1) LT2964622T (es)
MA (1) MA38423B1 (es)
ME (1) ME02814B (es)
MX (1) MX355436B (es)
MY (1) MY192027A (es)
NI (1) NI201500122A (es)
PE (1) PE20151591A1 (es)
PL (1) PL2964622T3 (es)
PT (1) PT2964622T (es)
RS (1) RS56224B1 (es)
SG (1) SG11201506952YA (es)
SI (1) SI2964622T1 (es)
SM (1) SMT201700351T1 (es)
TN (1) TN2015000367A1 (es)
TW (1) TWI506023B (es)
UA (1) UA118550C2 (es)
UY (1) UY35356A (es)
WO (1) WO2014135776A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087915A1 (en) 2010-06-03 2012-04-12 Pharmacyclics, Inc. Use of inhibitors of bruton's tyrosine kinase (btk)
MX2015001081A (es) 2012-07-24 2015-10-14 Pharmacyclics Inc Mutaciones asociadas a resistencia a inhibidores de la tirosina cinasa de bruton (btk).
US20150291554A1 (en) 2012-11-02 2015-10-15 Pfizer Inc. Bruton's Tyrosine Kinase Inhibitors
FR3002733B1 (fr) 2013-03-04 2015-08-14 Servier Lab Nouveau sel de l'abexinostat, forme cristalline associee,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US9885086B2 (en) 2014-03-20 2018-02-06 Pharmacyclics Llc Phospholipase C gamma 2 and resistance associated mutations
FR3025197B1 (fr) * 2014-09-03 2019-09-06 Pharmacyclics, Inc. Nouveau sel de 3-[(dimethylamino)methyl]-n-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofurane-2-carboxamide, formes cristallines associees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3025196B1 (fr) * 2014-09-03 2019-09-06 Pharmacyclics, Inc. Nouveaux sels de 3-[(dimethylamino)methyl]-n-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofurane-2-carboxamide, formes cristallines associees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2017002858A (es) * 2014-09-03 2017-10-24 Pharmacyclics Llc Sales novedosas de 3-[(dimetilamino)metil]-n-{2-[4-(hidroxicarbamo il)fenoxi]etil}-1-benzofuran-2-carboxamida, formas cristalinas relacionadas, metodo para preparar las mismas y las composiciones farmaceuticas que contiene las mismas.
WO2017011314A1 (en) * 2015-07-10 2017-01-19 Paharmacyclics Llc Btk and hdac combinations
EP4351734A1 (en) 2021-06-10 2024-04-17 Teva Pharmaceuticals International GmbH Solid state forms of abexinostat and process for preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3038004A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Quaternary ammonium compounds
GB0020721D0 (en) * 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
WO2004092115A2 (en) * 2003-04-07 2004-10-28 Axys Pharmaceuticals Inc. Hydroxamates as therapeutic agents
US20090270497A1 (en) * 2008-04-24 2009-10-29 Pharmacyclics, Inc. Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
US8603521B2 (en) * 2009-04-17 2013-12-10 Pharmacyclics, Inc. Formulations of histone deacetylase inhibitor and uses thereof
AU2010299483B2 (en) * 2009-09-24 2014-08-28 Sun Pharmaceutical Industries Limited Process for the preparation of sorafenib tosylate
WO2013039956A2 (en) * 2011-09-14 2013-03-21 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating mood disorders
FR3002733B1 (fr) 2013-03-04 2015-08-14 Servier Lab Nouveau sel de l'abexinostat, forme cristalline associee,leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CN105263917A (zh) 2016-01-20
LT2964622T (lt) 2017-08-10
CA2903369C (en) 2021-06-08
FR3002733A1 (fr) 2014-09-05
CN105263917B (zh) 2018-11-20
BR112015021443A2 (pt) 2017-07-18
WO2014135776A1 (fr) 2014-09-12
CA2903369A1 (en) 2014-09-12
TWI506023B (zh) 2015-11-01
IL241038B (en) 2019-09-26
AU2018202881B2 (en) 2020-02-27
UY35356A (es) 2014-09-30
EA039113B1 (ru) 2021-12-06
EA030689B1 (ru) 2018-09-28
CN109734690B (zh) 2023-08-11
JO3402B1 (ar) 2019-10-20
AU2014224456A8 (en) 2015-10-22
PT2964622T (pt) 2017-07-13
US20170313671A1 (en) 2017-11-02
JP6449177B2 (ja) 2019-01-09
JP6720280B2 (ja) 2020-07-08
TW201434822A (zh) 2014-09-16
US9115108B2 (en) 2015-08-25
DK2964622T3 (en) 2017-07-31
JP2019069955A (ja) 2019-05-09
ES2632471T3 (es) 2017-09-13
AU2014224456A1 (en) 2015-10-08
PE20151591A1 (es) 2015-11-06
SI2964622T1 (sl) 2017-10-30
NZ712380A (en) 2020-10-30
UA118550C2 (uk) 2019-02-11
IL241038A0 (en) 2015-11-30
FR3002733B1 (fr) 2015-08-14
PL2964622T3 (pl) 2017-10-31
HRP20171041T1 (hr) 2017-10-06
US20150315167A1 (en) 2015-11-05
MY192027A (en) 2022-07-23
EP3252044A1 (fr) 2017-12-06
AU2014224456B2 (en) 2018-01-25
MA38423B1 (fr) 2017-10-31
AU2018202881A1 (en) 2018-05-17
MX2015011566A (es) 2016-06-24
US20140249215A1 (en) 2014-09-04
CY1119147T1 (el) 2018-02-14
SMT201700351T1 (it) 2017-09-07
CL2015002488A1 (es) 2016-03-11
JP2016510735A (ja) 2016-04-11
RS56224B1 (sr) 2017-11-30
TN2015000367A1 (fr) 2017-01-03
HK1220965A1 (zh) 2017-05-19
GEP201706760B (en) 2017-10-25
US10150748B2 (en) 2018-12-11
SG11201506952YA (en) 2015-10-29
EA201591530A1 (ru) 2016-01-29
EA201891023A1 (ru) 2019-03-29
HUE035299T2 (en) 2018-05-02
NI201500122A (es) 2018-10-18
MX355436B (es) 2018-04-18
ME02814B (me) 2018-01-20
EP2964622A1 (fr) 2016-01-13
EP2964622B1 (fr) 2017-04-19
MA38423A1 (fr) 2017-02-28
CR20150456A (es) 2015-10-21
CN109734690A (zh) 2019-05-10
DOP2015000215A (es) 2015-09-30

Similar Documents

Publication Publication Date Title
AR094935A1 (es) Tosilato de n-hidroxi-4-{2-[3-(n,n-dimetilaminometil)benzofuran-2-ilcarbonil-amino]etoxi}benzamida (abexinostat)
JO3433B1 (ar) حلقة كاربوكسامايد ذات أربع أعضاء للاستخدام كمبيدات النيماتودا
UA116920C2 (uk) Інгібітори fgfr4
TR201900038T4 (tr) GPR6'nın tetrahidropiridopirazin modülatörleri.
MX393838B (es) Uso de compuestos heterociclicos para controlar nematodos.
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20150470A (es) Derivados de triazolona de piridinilo y piridinilo fusionado
UY34472A (es) Derivados modificados de 4-fenil-piridina
UY34825A (es) Síntesis de compuestos heterocíclicos
EA201790715A1 (ru) Новые соединения
IL249187B (en) Antibodies to il-15
UY36480A (es) Uso de compuestos de picolinamida como fungicidas
EA201692219A1 (ru) Способы получения противовирусных соединений
CU20150129A7 (es) Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34365A (es) Compuestos heterociclicos
CL2015002311A1 (es) Derivado de piridina monocíclico
TR201905217T4 (tr) Kopanlisib ve bunun dihidroklorid tuzunun sentezi.
UY37517A (es) Métodos de síntesis de compuestos tiazoles sustituidos
UY34115A (es) Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo
EA201591349A1 (ru) Способ получения вортиоксетина
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
CR20150417A (es) Compuestos de azetidiniloxifenilpirrolidina
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
BR112016027455A2 (pt) moduladores ppar

Legal Events

Date Code Title Description
FB Suspension of granting procedure